We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.76%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$41.2B
AUM Growth
+$286M
(+0.7%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-4.33%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
795
New
95
Increased
203
Reduced
357
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$199M |
| 2 |
Bunge Global
BG
|
+$149M |
| 3 |
Parker-Hannifin
PH
|
+$132M |
| 4 |
Deere & Co
DE
|
+$122M |
| 5 |
Chemours
CC
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$243M |
| 2 |
Honeywell
HON
|
+$167M |
| 3 |
SPR
Spirit AeroSystems
SPR
|
+$136M |
| 4 |
Dover
DOV
|
+$133M |
| 5 |
3M
MMM
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.08% |
| 2 | Technology | 14.05% |
| 3 | Financials | 13% |
| 4 | Industrials | 10.25% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Nutanix
NTNX
$16B
| $5.04M | 0.01% |
+225,000
| New | +$4.92M |
|
|
DCPH
627
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.75M | 0.01% |
+250,000
| New | +$4.58M |
|
|
K
628
DELISTED
Kellanova
K
| $4.72M | 0.01% |
80,660
-642,940
| -89% | -$40.6M |
|
629
Warner Bros
WBD
$64.2B
| $4.69M | 0.01% |
+220,103
| New | +$5.18M |
|
|
CFRX
630
DELISTED
ContraFect Corporation
CFRX
| $4.55M | 0.01% |
5,125
+2,000
| +64% | +$1.89M |
|
|
ESL
631
DELISTED
Esterline Technologies
ESL
| $4.52M | 0.01% |
+50,164
| New | +$4.52M |
|
632
Teva Pharmaceuticals
TEVA
$36.9B
| $4.4M | 0.01% |
+250,000
| New | +$5.63M |
|
633
Cencora
COR
$62.2B
| $4.37M | 0.01% |
52,800
-182,100
| -78% | -$15.4M |
|
634
Halozyme
HALO
$9.9B
| $4.34M | 0.01% |
250,000
-75,000
| -23% | -$1.02M |
|
|
SPR
635
DELISTED
Spirit AeroSystems
SPR
| $4.32M | 0.01% |
55,554
-1,962,707
| -97% | -$136M |
|
|
MANT
636
DELISTED
Mantech International Corp
MANT
| $4.26M | 0.01% |
96,397
| – | – |
|
637
Tenaris
TS
$28.1B
| $4.25M | 0.01% |
150,000
-250,000
| -63% | -$7.3M |
|
638
KALA BIO
KALA
$12.3M
| $4.15M | 0.01% |
+73
| New | +$4.01M |
|
|
NXTM
639
DELISTED
NxStage Medical Inc.
NXTM
| $4.14M | 0.01% |
+150,000
| New | +$4M |
|
|
SRCL
640
DELISTED
Stericycle Inc
SRCL
| $4M | 0.01% |
55,800
-17,300
| -24% | -$1.27M |
|
641
Acushnet Holdings
GOLF
$6.05B
| $3.92M | 0.01% |
220,508
| – | – |
|
642
Dollar General
DG
$27.8B
| $3.68M | 0.01% |
+45,423
| New | +$3.4M |
|
643
AtriCure
ATRC
$2.02B
| $3.68M | 0.01% |
164,353
+50,000
| +44% | +$1.13M |
|
644
Neurogene
NGNE
$663M
| $3.55M | 0.01% |
+12,500
| New | +$3.59M |
|
|
MRNS
645
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.52M | 0.01% |
+150,000
| New | +$1.68M |
|
|
AMRN
646
Amarin Corp
AMRN
$293M
| $3.5M | 0.01% |
50,000
| – | – |
|
647
Pentair
PNR
$10.8B
| $3.4M | 0.01% |
74,450
-165,001
| -69% | -$7.09M |
|
648
Western Union
WU
$2.58B
| $3.39M | 0.01% |
176,693
-81,900
| -32% | -$1.56M |
|
649
argenx
ARGX
$54.6B
| $3.39M | 0.01% |
150,000
| – | – |
|
|
ADAP
650
DELISTED
Adaptimmune Therapeutics
ADAP
| $3.35M | 0.01% |
408,901
-50,000
| -11% | -$312K |
|
Similar funds
Adage Capital Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Adage Capital Partners held 795 positions worth $41.2B, up 0.7% from $40.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.78B in Q3 2017, closing 88 positions and reducing 357 holdings. Its most notable exit was 3M, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Kite Pharma, Inc. worth $98.9M.
- Adage Capital Partners's largest Q3 2017 buy was Kite Pharma, Inc.: 550,000 shares worth $98.9M.
- Adage Capital Partners added most to DuPont de Nemours in Q3 2017, an estimated $199M increase.
- Adage Capital Partners's biggest Q3 2017 reduction was GE Aerospace, cutting an estimated $243M.
- Adage Capital Partners fully exited 3M in Q3 2017, selling an estimated $125M.
- Adage Capital Partners's ten largest holdings make up 14% of its $41.2B portfolio in Q3 2017.
- Adage Capital Partners opened 95 new positions and closed 88 in Q3 2017.
- Adage Capital Partners's portfolio value rose 0.7% quarter-over-quarter to $41.2B.
Based on Adage Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.